Web14 jan. 2024 · Khoso Baluch is 61, he's been the Chief Executive Officer, Interim Principal Accounting Officer, and Director of CorMedix Inc since 2024. There are 9 older and 4 … Web11 mrt. 2024 · BERKELEY HEIGHTS, N.J., March 11, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (NASDAQ: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...
CorMedix Inc. (CRMD) CEO Khoso Baluch on Q2 2024 Results
Web17 mrt. 2024 · CorMedix, Inc. (NASDAQ:NASDAQ:CRMD) Q4 2024 Earnings Conference Call March 16, 2024 4:30 PM ETCompany ParticipantsDan Ferry - IR, LifeSci AdvisorsKhoso Baluch - Chief Executive... Web13 aug. 2024 · Good afternoon and welcome to the CorMedix’s second quarter 2024 earnings conference call. Leading the call today is Khoso Baluch, Chief Executive … stretch boards
CORMEDIX INC. ANNOUNCES EXECUTIVE LEADERSHIP …
Web12 mei 2024 · CorMedix, Inc. ( NASDAQ: CRMD) Q1 2024 Earnings Conference Call May 11, 2024 4:30 PM ET Company Participants Daniel Ferry - LifeSci Advisors Khoso Baluch - CEO & Director Matt David - EVP &... Web26 jun. 2024 · Directors Taunia Markvicka and Michael George have resigned their positions on CorMedix’s Board, effective immediately. Khoso Baluch, CorMedix Chief Executive Officer and a member of the Board stated, “I am excited to have Dr. Khan and Mr. Lefkowitz join the Company and to have Dr. Gelbfish as an observer to the Board. Web19. Defendant Matthew David (“David”) has served as CorMedix’s Chief Financial Officer at all relevant times. 20. Defendant Mounts has served as CorMedix’s Executive Vice President and General Counsel at all relevant times. 21. Defendants Baluch, David, and Mounts are sometimes referred to herein as the “Individual Defendants.” 22. stretch bodycon dresses